Human study · Research · 6 Oct 2026
In 84 patients age 21 or younger, colorectal cancer was usually already stage III or IV at diagnosis
Source: American Academy of Pediatrics 2026 National Conference
What the research found
Study (chart review presented at a meeting; not a journal paper with a DOI in this release). ScienceDaily carried the American Academy of Pediatrics account on 6 October 2026. Erica Arnold and colleagues reviewed records of 84 patients age 21 or younger diagnosed with colorectal cancer from 2012 to 2023, presented at the AAP 2026 National Conference in San Diego, 2–6 October 2026. Only 20 percent had a first- or second-degree family history. Most already had stage III or IV disease. More than one third later had recurrent disease, and nearly half died of the cancer. The authors list lower back pain, abdominal pain, bowel changes, weight loss, and rectal bleeding as signs that can be missed because the disease is still uncommon at these ages. Sex is not split in the release. This is a description of a small clinical series, not a screening rule. Educational notes. This is not medical advice.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
Read the original at American Academy of Pediatrics 2026 National Conference
More research news
- In mice, fear made hippocampal maps of a safe place and a dangerous place overlap
- In pregnant mice, immune activation at day 12.5 lined up with placental injury and autism-like traits in male fetuses only
- Support cells in brain tissue from 73 people with Parkinson's showed sex differences in energy-gene and myelin-gene activity
- In 10,362 adults, night-to-night swings in sleep timing lined up with a higher risk of serious cardiovascular events
- In a U.S. telephone survey of 442,906 adults, reported cannabis use lined up with higher odds of cardiovascular disease, especially stroke